Tikehau Capital, a global alternative asset manager, and Goldman Sachs Asset Management, have provided a HoldCo PIK facility to support Ardian’s acquisition of Biofarma, an Italian-based nutraceutical CDMO.
Through the provision of this facility, Tikehau Capital and Goldman Sachs Asset Management are partnering with Biofarma’s management team and Ardian to support the company’s growth strategy which seeks to consolidate the market in Europe.
With more than EUR230 million revenue, Biofarma is a leading European CDMO player in the development, manufacturing and packaging of health supplements, medical devices, probiotic-based drugs, and cosmetics.
